BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24957768)

  • 1. Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.
    Pochechueva T; Jacob F; Fedier A; Heinzelmann-Schwarz V
    Metabolites; 2012 Nov; 2(4):913-39. PubMed ID: 24957768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status.
    Anugraham M; Jacob F; Nixdorf S; Everest-Dass AV; Heinzelmann-Schwarz V; Packer NH
    Mol Cell Proteomics; 2014 Sep; 13(9):2213-32. PubMed ID: 24855066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
    Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
    Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
    Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sweet systems: technologies for glycomic analysis and their integration into systems biology.
    Chen S; Qin R; Mahal LK
    Crit Rev Biochem Mol Biol; 2021 Jun; 56(3):301-320. PubMed ID: 33820453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical approaches to perturb, profile, and perceive glycans.
    Agard NJ; Bertozzi CR
    Acc Chem Res; 2009 Jun; 42(6):788-97. PubMed ID: 19361192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
    Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
    J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers.
    Guo H; Abbott KL
    Adv Cancer Res; 2015; 126():281-303. PubMed ID: 25727151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Transcriptomics, Proteomics, and Glycomics Reveals the Association between Up-regulation of Sialylated N-glycans/Integrin and Breast Cancer Brain Metastasis.
    Peng W; Zhu R; Zhou S; Mirzaei P; Mechref Y
    Sci Rep; 2019 Nov; 9(1):17361. PubMed ID: 31758065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma.
    de Oliveira RM; Ornelas Ricart CA; Araujo Martins AM
    Front Oncol; 2017; 7():328. PubMed ID: 29379771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Roles of Glycans in Hematological Malignancies.
    Pang X; Li H; Guan F; Li X
    Front Oncol; 2018; 8():364. PubMed ID: 30237983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.
    Amin A; Bashir A; Zaki N; McCarthy D; Ahmed S; Lotfy M
    World J Gastroenterol; 2015 May; 21(20):6167-79. PubMed ID: 26034352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycomic analysis using glycoprotein immobilization for glycan extraction.
    Yang S; Li Y; Shah P; Zhang H
    Anal Chem; 2013 Jun; 85(11):5555-61. PubMed ID: 23688297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
    Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
    J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Pancreatic Ductal Adenocarcinoma-Related Aberrant Glycosylations: A Multilateral Approach of Lectin Microarray-Based Tissue Glycomic Profiling With Public Transcriptomic Datasets.
    Wagatsuma T; Nagai-Okatani C; Matsuda A; Masugi Y; Imaoka M; Yamazaki K; Sakamoto M; Kuno A
    Front Oncol; 2020; 10():338. PubMed ID: 32232009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
    Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
    BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of N-glycans and expression of their related glycogenes in the epithelial-mesenchymal transition of HCV29 bladder epithelial cells.
    Guo J; Li X; Tan Z; Lu W; Yang G; Guan F
    Molecules; 2014 Dec; 19(12):20073-90. PubMed ID: 25470275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
    Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
    Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycans as cancer biomarkers.
    Adamczyk B; Tharmalingam T; Rudd PM
    Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.